These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6184490)

  • 21. [Results of BCG immunotherapy in the management of bladder tumors].
    Samodai L; Kiss L; Kolozsy Z; Dauda G; Drinóczy M; Mohácsi L
    Orv Hetil; 1990 Aug; 131(31):1697-702. PubMed ID: 2205825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCG in the management of superficial bladder cancer.
    Guinan P; Richardson C; Hanna M; Rubenstein M
    Prog Clin Biol Res; 1989; 303():447-53. PubMed ID: 2675002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of chronic hepatitis B].
    Carreño V; Montaño L; Torres M
    Rev Clin Esp; 1983 Oct; 171(1):73-6. PubMed ID: 6197728
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer.
    Lamm DL
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S86-90. PubMed ID: 11010830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunostimulation in the treatment of rheumatoid arthritis (author's transl)].
    Rosenthal M
    Schweiz Rundsch Med Prax; 1977 Nov; 66(45):1431-4. PubMed ID: 928307
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunotherapy of human cancer.
    Hersh EM; Gutterman JU; Mavligit GM
    Adv Intern Med; 1977; 22():145-85. PubMed ID: 65906
    [No Abstract]   [Full Text] [Related]  

  • 27. Virus therapy for bladder cancer.
    Burke J
    Cytokine Growth Factor Rev; 2010; 21(2-3):99-102. PubMed ID: 20382064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy of malignant melanoma.
    Terry WD
    N Engl J Med; 1980 Nov; 303(20):1174-5. PubMed ID: 6999351
    [No Abstract]   [Full Text] [Related]  

  • 29. BCG vaccine in superficial bladder cancer.
    Sharma N; Prescott S
    BMJ; 1994 Mar; 308(6932):801-2. PubMed ID: 8167481
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD; Lamm DL
    Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
    Debruyne FM; van der Meijden AP; Franssen MP
    Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556
    [No Abstract]   [Full Text] [Related]  

  • 32. BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.
    Schreinemachers L; Van der Meyden A; Steerenberg P; Feitz W; Groothuis D; De Jong W; Debruyne F
    Chemioterapia; 1987 Jun; 6(2 Suppl):713-6. PubMed ID: 3334665
    [No Abstract]   [Full Text] [Related]  

  • 33. BCG therapy for superficial bladder cancer: fundamental aspects.
    Hudson ML; Ratliff TL
    In Vivo; 1991; 5(6):643-6. PubMed ID: 1810450
    [No Abstract]   [Full Text] [Related]  

  • 34. BCG in the management of superficial bladder cancer.
    Robinson MR
    Prog Clin Biol Res; 1985; 185B():161-6. PubMed ID: 3898140
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of immunochemotherapy in malignant melanoma].
    Duchková H; Richter J; Kubíková M; Peska J; Ragan J; Vohryzková E; Hrivnáková J; Kvasnicka J
    Cesk Dermatol; 1980 Aug; 55(4):277-80. PubMed ID: 7407970
    [No Abstract]   [Full Text] [Related]  

  • 36. A trial of bacillus Calmette-Guérin versus adriamycin in superficial bladder cancer: a South-West Oncology Group Study.
    Mori K; Lamm DL; Crawford ED
    Urol Int; 1986; 41(4):254-9. PubMed ID: 3538593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term protection in bladder cancer following intralesional immunotherapy.
    Reichert DF; Lamm DL
    J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunotherapy in superficial bladder carcinoma].
    Ríos González E; Martínez-Piñeiro Lorenzo L; Martínez-Piñeiro Caramés JA; de la Peña Barthel JJ
    Arch Esp Urol; 2000 Dec; 53(10):879-92. PubMed ID: 11213392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial.
    Hudson MA; Ratliff TL; Gillen DP; Haaff EO; Dresner SM; Catalona WJ
    J Urol; 1987 Aug; 138(2):295-8. PubMed ID: 3298694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the treatment of superficial bladder cancer: optimizing BCG immunotherapy. Introduction.
    Lamm DL
    Eur Urol; 1995; 27 Suppl 1():1. PubMed ID: 7750524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.